Medical Devices Startups
6,515 companies tagged Medical Devices, with their investors and founders.
Actinium is developing targeted radiotherapy treatments using Actinium-225 and related isotopes for oncology indications including prostate cancer, non-small cell lung cancer, breast cancer, and acute myeloid leukemia. The company's lead candidates include ATNM-400 for solid tumors and Actimab-A for blood malignancies.
0 investors
ActivArmor makes custom-fit, 3D printed waterproof casts and splints that let patients stay active while healing from fractures and injuries. The technology is offered to medical providers to use at their practices as an alternative to traditional casts.
0 investors
BoneScore makes the OsteoProbe, a handheld, radiation-free medical device that measures bone tissue strength by delivering a controlled impact and producing a Bone Material Strength Index (BMSi). Spun out of UC Santa Barbara and FDA-cleared, it is used in clinical settings to assess fracture risk in patients, including for conditions such as osteoporosis, diabetes, and kidney disease.
0 investors
Acuitive Technologies is an orthopedic medical device company developing products using citrate-based biodegradable biomaterials for regenerative applications, including foot and ankle surgery. Its team consists of veterans of the orthopedic industry drawn from companies such as J&J, Zimmer, Stryker, and MAKO.
0 investors
AMM operates higher-acuity urgent care facilities that deliver emergency-level acute care in community settings, reducing unnecessary emergency department visits while improving patient outcomes and experience. The company partners with healthcare systems to develop and operate advanced diagnostic and treatment centers across New Jersey.
0 investors
Adapt Biotechnologies develops the BRiTE platform, a bispecific antibody technology designed to treat brain tumors and intracerebral malignancies by activating T cells to target and destroy glioma cells. The platform combines manipulated T cells with bispecific antibodies to deliver targeted therapy to brain tissue.
0 investors
Adial Pharmaceuticals is a biopharmaceutical company developing treatments for addiction and inflammatory disease, including AT177, a colon-targeted AhR agonist for ulcerative colitis, and AD04, a genetically targeted serotonin-3 receptor antagonist in Phase 3 trials for Alcohol Use Disorder. It is publicly listed on Nasdaq under the ticker ADIL.
0 investors
ADMdx develops medical imaging software and AI-based analysis tools for PET and MRI brain scans, including its PipelineMAX image processing platform and CorInsights products, to support neuroimaging research and clinical trials for neurological diseases such as Alzheimer's and Parkinson's. It serves pharmaceutical companies and researchers involved in drug development and clinical trial planning.
0 investors
Advanced NanoTherapies (ANT) develops next-generation drug-coated balloons (DCBs) using nanotechnology to treat vascular disease. The company operates in the medical device and nanomedicine field, focused on cardiovascular and endovascular interventions.
0 investors
Aesclepius Corporation develops orthopaedic surgical instruments and devices designed to improve patient outcomes in orthopedic surgery. The company holds provisional patents in multiple areas of orthopedic surgery and care.
0 investors
Aesthetics Biomedical develops and distributes novel aesthetic devices and products for the global market, serving physicians and aesthetic practitioners with innovation-focused solutions and combination therapies.
0 investors
AffinityBio develops LifeScale, a diagnostic system that uses population-profiling technology to identify Gram-negative bacteria in positive blood cultures and perform antibiotic susceptibility testing in roughly 4.5 hours. The system automates sample inoculation, incubation, reading, and reporting for clinical microbiology labs.
0 investors
Ainos is a medtech company operating three business divisions: pharmaceuticals focused on low-dose interferon therapies, medical devices including AI-powered point-of-care diagnostics, and preventive medicine applications of mRNA technology. The company serves healthcare providers and patients across infectious disease, female health, and oncology treatment areas.
0 investors
AION Healthspan develops investigational cell-based and molecular therapies aimed at preventing, delaying, and reversing chronic, metabolic, and autoimmune conditions associated with aging. Building on research from the University of Miami's Diabetes Research Institute and Cell Transplant Center, the company works in regenerative medicine to extend healthy lifespan.
0 investors
Alamab Therapeutics is a biotechnology company developing therapeutics for acute spinal cord injury (ALMB-0166) and bone-involved cancers (ALMB-0168). It operates in the drug development / therapeutics industry.
0 investors
Aldeyra Therapeutics is a biopharmaceutical company developing therapies for eye diseases and other conditions. The company is led by a board of experienced pharmaceutical and life sciences executives.
0 investors
AlgometRx develops the Nociometer, a medical device that analyzes pupil dilation in response to neuroselective stimulation to objectively characterize pain type, intensity, and the effect of analgesics. Spun out of Children's National Hospital, its technology serves clinicians for pain assessment and treatment decisions, and pharmaceutical companies for analgesic drug development.
0 investors
AlignerAi provides patent-pending tools for managing clear aligner (orthodontic) therapy, including bite registration capture, pressure mapping, and AI-powered monitoring that compares patient data against the prescribed treatment plan. It serves dentists by tracking patient progress in real time to reduce chair visits and revisions while keeping patients compliant with treatment.
0 investors
All Flex manufactures flexible circuit boards, printed circuit board layers, and flexible heaters for industrial applications. The company serves customers across aerospace, medical, and other sectors requiring specialized circuit manufacturing with rapid turnaround and quality certifications.
0 investors
Allarity Therapeutics is a clinical-stage precision medicine company that uses its proprietary Drug Response Predictor technology to match cancer patients with therapies tailored to their disease. The company develops oncology drugs for difficult-to-treat cancers and is focused on improving patient outcomes through personalized treatment approaches.
0 investors
Allevion Therapeutics is a medical device company developing technologies in the healthcare and medtech space. Its team has a background in cardiac arrhythmia, atrial fibrillation, and neurological/movement disorder treatments.
0 investors
Alta Smiles develops the V5x, a smartphone-based imaging device for dental and orthodontic providers to capture high-quality intra and extraoral photos in-office and enable remote patient monitoring during treatment. The system reduces appointment time and improves workflow efficiency for dental practices.
0 investors
AltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
0 investors
Alzpath develops diagnostic tools for early and accurate detection of Alzheimer's disease. The company serves clinicians and patients seeking improved diagnostic accuracy and accessibility across the care pathway.
0 investors